Senior Advisor at R & R Partners. Educated at Stockholm School of Economics in Business Administration and Economics. Experienced CFO and CEO from Medical device (Althin Medical) and Private Equity (Esalp Invest AB) business.
CSO and cofounder of Truly Labs AB and Truly Translational Sweden AB. Ph. D. In Medical Sciences from Lund University. Broad experience within In vivo pharmacology and pharmaceutical development of small molecules as well as biologics from Pharmacia Upjohn, Active Biotech, Cartela and AstraZeneca.
IngaLill Forslund Larsson
Partner at Lisberg Executive Search. Previously Marketing Director at AstraZeneca and Ferring Pharmaceuticals. Board member in life science companies, currently chairman of the board of XImmune AB, board member of LIDDS AB, and LU Bioscience AB.
Karin von Wachenfeldt
CEO and cofounder of Truly Labs AB and Truly Translational Sweden AB. Ph. D. In Immunotechnology from Lund University and Marketing Economist (EFL). Broad experience of early stage pharmaceutical development of small molecules and biopharmaceuticals from BioInvent, Pharmacia Upjohn, Active Biotech and AstraZeneca.
Principal Scientist and cofounder of Truly Labs AB. Extensive experience of the pharmaceutical industry with more than twenty years of drug discovery, in vivo pharmacology, and line management functions and thereafter management of clinical studies.